FAK is often overexpressed and hyperactivated in multiple aggressive cancers such as pancreatic cancer, mesothelioma and ovarian cancer and correlates with poor survival [5,32,35,37,38]. The gene discussed is PTK2; the disease is ovarian carcinoma.